CYP11B2 and adrenal cortex neoplasm: Of the remaining 24 (32%) adrenal glands with CYP11B2-negative adrenocortical tumors, 10 were associated with cNGS-identified mutation carriers and 14 had no cNGS-identified mutation (Supplementary Figure S3).